Key result
Wild-type and light-chain cardiac amyloidosis show similarly depressed longitudinal strain, worse than mutant TTR.
Why the study?
Detailed echocardiographic studies have been performed in AL amyloidosis but not in TTR amyloidosis, limiting insight into differences in prognosis between these cardiac amyloidosis types.
Does left ventricular structure and function differ between transthyretin-related and light-chain cardiac amyloidosis?
Observational (n=172)
Does left ventricular structure and function differ between transthyretin-related and light-chain cardiac amyloidosis?
Patients with ATTRwt cardiac amyloidosis have greater wall thickness but lower mortality than those with AL amyloidosis despite similar degrees of longitudinal strain impairment, suggesting additional mechanisms like light-chain toxicity in AL amyloidosis.
Answers are grounded in this paper and cite their sources.
Similar strain impairment in wild-type TTR and AL amyloidosis despite differing outcomes supports additional AL mechanisms; leaves open causal inference.
BACKGROUND: Immunoglobulin amyloid light-chain (AL)-related cardiac amyloidosis (CA) has a worse prognosis than either wild-type (ATTRwt) or mutant (ATTRm) transthyretin (TTR) CA. Detailed echocardiographic studies have been performed in AL amyloidosis but not in TTR amyloidosis and might give insight into this difference. We assessed cardiac structure and function and outcome in a large population of patients with CA and compared findings in TTR and AL-related disease. METHODS AND RESULTS: We analyzed 172 patients with CA (AL amyloidosis, n=80; ATTRm, n=36; ATTRwt, n=56) by standard echocardiography and 2-dimensional speckle-tracking imaging-derived left ventricular (LV) longitudinal (LS), radial, and circumferential strains. Despite a preserved LV ejection fraction (55±12%), LS was severely impaired in CA. Standard measures of LV function and speckle-tracking imaging worsened as wall thickness increased, whereas apical LS was preserved regardless of the pathogenesis of CA and the degree of wall thickening. Compared with ATTRm and AL amyloidosis, ATTRwt was characterized by greater LV wall thickness and lower ejection fraction. LS was more depressed in both ATTRwt and AL amyloidosis (-11±3% and -12±4%, respectively, P=0.54) than in ATTRm (-15±4%, P<0.01 versus AL amyloidosis and ATTRwt). TTR-related causes were favorable predictors of survival, whereas LS and advanced New York Heart Association class were negative predictors. CONCLUSIONS: In patients with CA, worsening LV function correlated with increasing wall thickness regardless of pathogenesis. Patients with ATTRwt had a statistically greater wall thickness but lesser mortality than those with AL amyloidosis, despite very similar degrees of LS impairment. This paradox suggests an additional mechanism for LV dysfunction in AL amyloidosis, such as previously demonstrated light-chain toxicity.
No takes yet. Share an insight, caveat, or question.
Quarta et al. (2014) conducted an observational in Cardiac amyloidosis (n=172). Transthyretin-related cardiac amyloidosis (ATTRwt) vs. Light-chain cardiac amyloidosis (AL) was evaluated on Left ventricular longitudinal strain (LS) (p=0.54). Wild-type transthyretin and light-chain cardiac amyloidosis showed similarly depressed left ventricular longitudinal strain, which was worse than in mutant TTR.
Synapse has enriched 10 related papers. Consider them for comparative context: